Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of 17beta-estradiol Treatment on Insulin Sensitivity, Immune Function, Inflammation and Skeletal Muscle Metabolism Following Exercise Training in Sedentary, Overweight Males

NCT07791394 is registered in ClinicalTrials.gov with University of Waterloo as lead sponsor.

NCT NCT07791394
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07791394 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of 17beta-estradiol Treatment on Insulin Sensitivity, Immune Function, Inflammation and Skeletal Muscle Metabolism Following Exercise Training in Sedentary, Overweight Males
Lead sponsor
University of Waterloo
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 31, 2026
Completion date
April 30, 2027
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

to determine whether estrogen influences the effects of training on glycemic control and insulin sensitivity